chevron_leftBack
As of 17 June 2026, Jiangsu Aidea Pharmaceutical Group Co., Ltd. has a market cap of $1.08B USD, ranking #10345 globally and #2879 in China.
It ranks #917 in the Healthcare sector, and #345 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.08BUSD
7.28B CNY
Enterprise Value
$1.11BUSD
7.5B CNY
Revenue (TTM)
$106.21MUSD
719.17M CNY
EBITDA (TTM)
$12.87MUSD
87.11M CNY
Net Income (TTM)
-$2.88MUSD
-19.53M CNY
EBITDA Margin
12%
Profit Margin
-2.7%
PS Ratio
10.1
PB Ratio
6.8
EV/EBITDA
83.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jie Zhang
open_in_new
Employees
735
Founded
2009
Website
aidea.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | -4.9% | 8% | -1.1% | 20% | 58% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688488
江苏艾迪药业股份有限公司 Class A
ISIN: CNE1000041S6
Shares Out.:
Shares Outstanding:
420.783M1
Shares Float:
420.746M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
17.26 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.89B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.67B
5K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
71K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
51K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
33K%
|
97.4
|
|
SIX: RO
|
$322.73B
30K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
27K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
26K%
218.9B CHF
|
20.5
|
chevron_leftBack